Manankova N M, Nesterenko E A, Argutinskaia S V, Salganik R I
Vopr Med Khim. 1979 Jul-Aug;25(4):456-60.
Activity of microsomal enzymes and the patterns of cholesterol metabolism were studied in mice of WSR/y strain, characterized by spontaneous development of atherosclerosis within the later periods of life, after early postnatal administration of an inductor of the enzymes 3-acetate-16 alpha-isothiocyanopregnenolone (ATCP). Administration of ATCP into newborn mice of SWR/y strain, from the 2nd up to 16th day after birth, led to a stable increase in activity of arylhydrocarbonate hydroxylase (an enzyme participating in unspecific metabolism of drugs), which was observed during the whole experimental period (4 months). The treatment with ATCP caused also a distinct increase in activity of cholesterol-7 alpha-hydroxylase (a key enzyme of cholesterol biotransformation and elimination) as well as a considerable decrease in content of cholesterol and lipoprotein atherogenic fractions in blood serum. The rate of cholesterol biosynthesis was similar both in mice treated with ATCP and in the control animals.
在出生后早期给予酶诱导剂3-乙酸-16α-异硫氰基孕烯醇酮(ATCP)后,对WSR/y品系小鼠的微粒体酶活性和胆固醇代谢模式进行了研究。该品系小鼠的特点是在生命后期会自发发展为动脉粥样硬化。在出生后第2天至第16天给SWR/y品系新生小鼠施用ATCP,导致芳烃羟化酶(一种参与药物非特异性代谢的酶)的活性持续稳定增加,在整个实验期(4个月)内均观察到这一现象。用ATCP处理还导致胆固醇-7α-羟化酶(胆固醇生物转化和消除的关键酶)的活性显著增加,以及血清中胆固醇和致动脉粥样硬化脂蛋白组分的含量大幅降低。用ATCP处理的小鼠和对照动物的胆固醇生物合成速率相似。